Showing 1 - 7 results of 7 for search 'Wolfgang Jacob', query time: 0.04s Refine Results
  1. 1
    Deuterium plasma exposure of thin oxide films on tungsten - oxygen removal and deuterium uptake

    Deuterium plasma exposure of thin oxide films on tungsten - oxygen removal and deuterium uptake by Kristof Kremer, Thomas Schwarz-Selinger, Wolfgang Jacob

    Published 2023-06-01
    Get full text
    Article
  2. 2
    Influence of thin tungsten oxide films on hydrogen isotope uptake and retention in tungsten – Evidence for permeation barrier effect

    Influence of thin tungsten oxide films on hydrogen isotope uptake and retention in tungsten – Evidence for permeation barrier effect by Kristof Kremer, Thomas Schwarz-Selinger, Wolfgang Jacob

    Published 2021-06-01
    Get full text
    Article
  3. 3
    Bonding States of Hydrogen in Plasma-Deposited Hydrocarbon Films

    Bonding States of Hydrogen in Plasma-Deposited Hydrocarbon Films by Wolfgang Jacob, Thomas Dürbeck, Thomas Schwarz-Selinger, Udo von Toussaint

    Published 2020-01-01
    Get full text
    Article
  4. 4
    Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy

    Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy by Michael A. Cannarile, Martin Weisser, Wolfgang Jacob, Anna-Maria Jegg, Carola H. Ries, Dominik Rüttinger

    Published 2017-07-01
    Get full text
    Article
  5. 5
    Direct estrogen receptor (ER) / HER family crosstalk mediating sensitivity to lumretuzumab and pertuzumab in ER+ breast cancer.

    Direct estrogen receptor (ER) / HER family crosstalk mediating sensitivity to lumretuzumab and pertuzumab in ER+ breast cancer. by Denis Collins, Wolfgang Jacob, Juan Miguel Cejalvo, Maurizio Ceppi, Ian James, Max Hasmann, John Crown, Andrés Cervantes, Martin Weisser, Birgit Bossenmaier

    Published 2017-01-01
    Get full text
    Article
  6. 6
    A phase Ib/II study of HER3-targeting lumretuzumab in combination with carboplatin and paclitaxel as first-line treatment in patients with advanced or metastatic squamous non-small cell lung cancer

    A phase Ib/II study of HER3-targeting lumretuzumab in combination with carboplatin and paclitaxel as first-line treatment in patients with advanced or metastatic squamous non-small... by Enriqueta Felip, Juan-Miguel Cejalvo, Wolfgang Jacob, Tania Fleitas Kanonnikoff, Alejandro Navarro Mendivil, Maria Martinez Garcia, Alvaro Taus Garcia, Natasha Leighl, Ulrik Lassen, Morten Mau-Soerensen, Celine Adessi, Francesca Michielin, Ian James, Maurizio Ceppi, Max Hasmann, Martin Weisser

    Published 2019-07-01
    Get full text
    Article
  7. 7
    Phase Ib study of anti-CSF-1R antibody emactuzumab in combination with CD40 agonist selicrelumab in advanced solid tumor patients

    Phase Ib study of anti-CSF-1R antibody emactuzumab in combination with CD40 agonist selicrelumab in advanced solid tumor patients by Jean-Marie Michot, Wolfgang Jacob, Francesca Michielin, Martin Weisser, Dmitriy Zamarin, Jean-Pascal Machiels, Anna-Maria Jegg, Dominik Rüttinger, Konstanty Korski, Jean-Pierre Delord, Carlos Gomez-Roca, Tara Mitchell, Gaetan Catala, Lauriane Eberst, Michael A Cannarile, Carl Watson, Galina Babitzki, Irina Klaman, Priscila Teixeira, Sabine Hoves, Carola Ries, Georgina Meneses-Lorente, Randolph Christen, Philippe Cassier

    Published 2020-10-01
    Get full text
    Article

Search Tools: